Scientist who died on MH17 brought HIV cure to poor

Image
IANS London
Last Updated : Jul 21 2014 | 4:06 PM IST

Dutch clinical virologist Joep Lange - who was among 298 passengers who died in the downing of Malaysia Airlines flight MH17 - worked since the early 1990s to deliver HIV drugs deep into the world's poorest countries.

He was one of the six scientists headed to attend the six-day 20th International AIDS Conference in Melbourne that started Sunday.

Lange's death has shocked the international public health and medical research communities, the scientific journal Nature reported.

"His contribution to HIV research and treatment and his determination to ensure access of those treatments for people in Africa and Asia, cannot be underestimated," said David Cooper, an AIDS researcher at University of New South Wales in Sydney.

Lange was a clinical virologist at University of Amsterdam.

His research explored HIV drug resistance, the role of anti-retroviral drugs in preventing transmission of virus from mother to child and other issues related to managing HIV AIDS.

His work helped to establish the safety and effectiveness of treating patients with multiple antiviral drugs, which is now standard.

In 2000, Lange helped launch the non-profit PharmAccess Foundation to bring anti-retroviral drugs to sub-Saharan Africa, where the HIV epidemic was in full swing and most patients remained untreated.

The foundation has since broadened its reach, creating a fund that subsidises health insurance for about 1,00,000 people in Nigeria, Tanzania and Kenya.

"This is a massive loss. We are devastated. Joep's dedication to the treatment of HIV AIDS and global health in general has been ground breaking," said Onno Schellekens, managing director of PharmAccess.

"He was very selfless. He believed we have made great scientific progress and people have to benefit from it," Robin Weiss, a virologist at University College London, emphasised.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 21 2014 | 4:02 PM IST

Next Story